Distal Deep Vein Thrombosis in a Patient Cured of Severe COVID-19 Pneumonia at Jimma, Oromia, Ethiopia 2021: A Rare Case Report

Debela, Dejene Tolossa; Ababulgu, Elias; Desu, Gaddisa; Abebe, Serkaddis; Adugna, Tesfaye

doi:10.2147/imcrj.s322301

Cited by 3 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In other studies of COVID-19 patients, Hesam-Shariati et al and Debela et al reported patients presenting with typical symptoms of DVT involving leg swelling, redness, calf tenderness, and decreased limb mobility [12,13]. While our patient was clinically asymptomatic, DVT was suspected based on persistently elevated Ddimer levels for several weeks post-recovery and confirmed by Doppler ultrasonography.…”

Section: Discussionsupporting

confidence: 52%

A Case of Deep Vein Thrombosis After Recovery From COVID-19 and Its Association With Elevated D-dimers

Dasari¹,

Banga²,

Pallipamu³

et al. 2022

Cureus

View full text Add to dashboard Cite

The coronavirus disease 2019 continues to be a devastating disease for the elderly population, especially in long-term care facilities, and it presents with varying clinical presentations. We have ample evidence that COVID-19 can predispose to deep vein thrombosis (DVT) and pulmonary embolism (PE) during an active infection. Still, very few cases of DVT have been reported after recovery from COVID-19.The imbalance of the coagulation cascade and the increased release of certain coagulation factors play an essential role in promoting hypercoagulability and vascular endothelial dysfunction. It leads to a rise in the level of fibrin degradation products, D-dimers, which can remain elevated for up to several weeks, even after recovery. It has been suggested that the risk of DVT occurring after recovering from COVID-19 remains high for up to three months.We report a case of a 77-year-old long-term care female resident at a nursing facility, ambulatory at baseline, who was noted to be COVID-19 positive upon routine facility-wide testing per department of health guidelines. She was asymptomatic during her 10-day quarantine period. D-dimer levels during routine labs were high (initial D-dimer level of 1.87 mg/L FEU {normal value: 0.19-0.52 mg/L FEU}), but the patient had no clinical signs and symptoms of DVT. Ultrasound of the bilateral legs was not performed due to low clinical suspicion. The patient received an enoxaparin DVT prophylaxis dose during the quarantine period. Follow-up D-dimer levels were done at frequent intervals after recovery, but D-dimer levels continued to remain elevated up till six weeks after her 10-day quarantine period ended. Based on previous experience with other long-term care residents who suffered from COVID-19, bilateral lower extremity ultrasound was performed, which showed bilateral DVT. Elevated D-dimer levels are a predictor of hypercoagulation complications in COVID-19. Patients with persistently elevated D-dimer levels after recovery from COVID-19 should be screened for thromboembolic complications, even if they are asymptomatic. DVT can occur up to three months post-recovery from COVID-19 infection.

show abstract